According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
i>Take off your shoes before you track dirt in the house.
Don't eat in THAT chair.
If you dirty a dish, wash it!
Cheryl hates disorder. The rest of ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
us who live in this house are NOT neat freaks. Not by a long shot. We seem to revel in disorder ... like most of the world. That is what makes it so difficult for everyone
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
o use the #1 best home-based business MLM strategy: FOCUS!
In the physical world, disorder is called "entropy." In 1856, Rudolf Clausius proposed the Law of Entropy: over
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
time, the entropy of any closed system increases. It's true even for my wife. Proof: just look inside her purse. She straightens it up on a regular basis because it gets w
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
ld in there on a regular basis.
Which brings me to your MLM business opportunity.
Here's what I see. You struggle for awhile, and then you figure out a system that really
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
works to build your network marketing business and train your people. In short order, you are successful. You are on your way to the classic MLM work-from-home dream of mo
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ney-freedom and time-freedom.
You get REALLY excited!
Your team is anticipating their own meteoric rise. The thought going around is, "We're going to rule the worl
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
!"
But success creates another effect: the opportunity for your network marketing business to branch out in different directions. What could be more natural? You've got a
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
system. You've already won the game. Now it's time to conquer new territory. Multiple streams of income, here we come!
Unfortunately, that law of entropy is about to smack
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
you upside the head. The natural state of things is to become disordered. And now you and your associates are speeding up the process by widening your horizons or ... put a
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
nother way ... losing your focus.
Even the most successful businesses, once you scratch the surface, have lots of problem areas:
- There's maybe a feeling now that
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
you can coast a bit.
Products are getting dated.
Advertising response falls off and suddenly it costs a lot more money for the same results.
That "gung-hocts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
customer service attitude doesn't seem as crucial, now that you are successful.
MLM success breeds confidence, and confidence often breeds ego ... which can br
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
eed disaster. It happens to people a whole lot smarter - and with a whole lot more money - than you & I.
Look at Xerox
They built a business whose name became syno
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ymous with "copies". The world was their oyster. In the early 1980s, they branched out into insurance, mutual funds, and investment banking. In 1992, they dropped all these
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
financial services at a loss of nearly a billion dollars. They got out before "conquering new territory" cost them their entire business. There are hundreds of other examp
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
les, but the point is obvious.
The bigger your empire, the more disorder you will suffer. When you see those smiling faces of the top earners up on stage at Convention, re
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
lize that they are either now or will soon be experiencing serious disorder. The hoped-for multiple streams of income will soon become multiple streams of outgo. Why? Becau
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
se disorder is the LAW!
Solution? Focus. Focus. Focus. Resist all temptations to unfocus. In the long run, the most successful MLM team - and people - are the most focused
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products